The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Objective response and prolonged stable disease in refractory adrenocortical carcinoma treated with cabozantinib: An international case series and protocols of phase II clinical trials.
 
Matthias Kroiss
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Felix Megerle
No Relationships to Disclose
 
Julia Wendler
No Relationships to Disclose
 
Camilo Jimenez
No Relationships to Disclose
 
Marcus Quinkler
No Relationships to Disclose
 
Uwe Malzahn
No Relationships to Disclose
 
Maria-Elisabeth Goebeler
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Pfizer; Roche Pharma AG
Expert Testimony - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Pfizer; Roche
 
Martin Fassnacht
No Relationships to Disclose
 
Mouhammed Amir Habra
Research Funding - Exelixis (Inst); HRA Pharma (Inst)